Form D — Aviceda Therapeutics, Inc.
0001824762-25-000001 · filed 2025-01-13
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $207,499,882
- Total sold
- $74,999,940
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aviceda Therapeutics, Inc.
- CIK
- 1824762
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- ONE BROADWAY, 14TH FLOOR
CAMBRIDGE, MA 02142 - Phone
- 617-332-0741
Related persons
-
Mohamed Genead · Executive OfficerCambridge, MA
-
Michael Tolentino · Executive OfficerCambridge, MA
-
Nancy Thomason · DirectorCambridge, MA
-
Christoph Adams · DirectorCambridge, MA
-
David Guyer · DirectorCambridge, MA
-
Jay Woods · DirectorCambridge, MA
-
Erin Lavelle · DirectorCambridge, MA
-
David Callanan · Executive OfficerCambridge, MA
-
Tarek Hassan · Executive OfficerCambridge, MA
-
Derek Kunimoto · Executive OfficerCambridge, MA
View original on SEC EDGAR.